Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Am J Kidney Dis. 2012 Jun 2;60(2):250–261. doi: 10.1053/j.ajkd.2012.04.012

Table 1. Demographic and clinical characteristics.

Entire Cohort (n=3939) Participants in GFR Subcohort P-value
Yes (n=1433) No (n=2506)
mGFR
 including first clearance period (mL/min/1.73 m2) - 49.0 ±21.0) - -
 excluding first clearance period (mL/min/1.73 m2) - 48.0 ±19.9) - -
Age (y) 58.2 ±11.0) 56.0 ±12.3) 59.4 ±10.0) <0.001
Female gender 1778 (45.1) 628 (43.8) 1150 (45.9) 0.2
Black race 1658 (42.1) 534 (37.3) 1124 (44.9) <0.001
Hispanic 497 (12.6) 215 (15.0) 282 (11.3) <0.001
Diabetes present 1907 (48.4) 689 (48.1) 1218 (48.6) 0.8
Height (cm) 168.8 ±9.7) 168.9 ±9.5) 168.8 ±9.8) 0.7
Weight (kg) 91.5 ±23.4) 89.4 ±21.0) 92.8 ±24.6) <0.001
BMI (kg/m2) 32.1 ±7.8) 31.3 ±6.9) 32.5 ±8.3) <0.001
Waist circumference (cm) 105.8 ±17.6) 103.8 ±16.1) 107.0 ±18.3) <0.001
BIA resistance (ohm) 463.9 ±104.4) 467.9 ±101.3) 461.6 ±106.2) 0.07
BIA reactance (ohm) 54.4 ±26.0) 54.8 ±23.6) 54.1 ±27.2) 0.5
BIA phase angle (degrees) 6.9 ±4.2) 6.8 ±3.7) 6.9 ±4.5) 0.5
Fat-free mass (kg) 60.5 ±15.6) 59.8 ±15.0) 61.0 ±15.9) 0.03
Impedance (ohm) 468.2 ±102.7) 472.2 ±99.9) 465.9 ±104.2) 0.07
Serum creatinine (mg/dL) 1.74 ±0.58) 1.70 ±0.57) 1.77 ±0.58) <0.001
Serum cystatin C (mg/L) 1.52 ±0.55) 1.46 ±0.52) 1.55 ±0.56) <0.001
Serum albumin (g/dL) 3.9 ±0.5) 3.9 ±0.5) 4.0 ±0.5) <0.001
SUN (mg/dL) 29.6 ±13.6) 29.3 ±13.3) 29.9 ±13.8) 0.2
24-h urine protein (mg/d) 184.3 [73.1-910.0] 210.8 [76.5-1073.1] 171.1 [71.4-839.5] 0.01
24-h urine creatinine (mg/dL) 70.8 ±36.9) 68.0 ±35.0) 72.4 ±37.9) <0.001
24-h urine creatinine (g/d) 1.3 ±0.6) 1.4 ±0.6) 1.3 ±0.6) 0.002
UPCR (mg/g)* 152.5 [57.5-777.8] 160.8 [59.1-941.4] 145.9 [56.3-724.0] 0.08
24-h urine albumin (mg/d) 64.3 [10.3-558.7] 84.1 [10.8-646.7] 57.8 [9.9-508.6] 0.004
24-h urine urea nitrogen (g/d) 8.6 ±4.4) 8.8 ±4.3) 8.5 ±4.5) 0.08
Plasma glucose (mg/dL) 115.4 ±51.7) 112.7 ±48.8) 117.0 ±53.2) 0.01
Total plasma homocysteine (mg/L) 2.0 ±0.8) 2.0 ±0.8) 2.1 ±0.9) <0.001
hsCRP (mg/L) 2.6 [1.1-6.5] 2.2 [0.9-5.2] 2.8 [1.1-7.1] <0.001
BNP (pg/mL) 40.6 [17.0–96.0] 36.7 [15.4-83.6] 43.1 [18.0-101.9] <0.001
Fibrinogen (mg/dL) 416.9 ±121.1) 403.8 ±118.3) 424.4 ±122.1) <0.001
Insulin (μU/mL) 16.3 [10.9-25.4] 15.6 [10.5-24.6] 16.5 [11.2-25.9] 0.01
IL-6 (pg/mL) 1.9 [1.2-3.2] 1.7 [1.1-2.8] 2.0 [1.2-3.4] <0.001
TNF-α (pg/mL) 2.2 [1.5-3.2] 2.2 [1.5-3.3] 2.2 [1.5-3.2] 0.6
IL-1ra (pg/ml) 715.7 [390-1551] 715.0 [370-1508] 717.1 [397-1569] 0.1
Urine NGAL (ng/ml) 14.9 [5.0-35.4] 13.9 [5.0-32.2] 15.5 [5.0-38.0] 0.004
Creatinine clearance (mL/min) 58.2 ±30.5) 61.2 ±31.1) 56.5 ±30.0) <0.001
HOMA-IR 6.6 ±8.7) 6.3 ±7.7) 6.8 ±9.2) 0.1
SI-HOMA 0.2 [0.1-0.4] 0.3 [0.1-0.4] 0.2 [0.1-0.4] 0.02
Body surface area (m2) 2.06 ±0.29) 2.04 ±0.27) 2.07 ±0.30) <0.001

Note: unless otherwise indicated, values for continuous variables given as mean ± SD or median [25th-75th percentile], while values for categorical variables given as number (percentage).

BIA – bioelectrical impedance analysis; BMI – body mass index; BNP – brain natriuretic protein; GFR – glomerular filtration rate; HOMA-IR – homeostasis model assessment – insulin resistance; hsCRP – high-sensitivity C-reactive protein; IL-1ra – interleukin 1 receptor antagonist; IL-6 – interleukin 6; mGFR – measured GFR; NGAL – neutrophil gelatinase-associated lipocalin; SI-HOMA – homeostasis model assessment – insulin sensitivity; Sun, serum urea nitrogen; TNF-α - tumor necrosis factor α; UPCR, urine protein-creatinine ratio.

*

Determined from 24-h urine sample

From BIA data

Traceable to isotope dilution mass spectrometry.

Note: Conversion factors for units: creatinine in mg/dL to μmol/L, ×88.4; creatinine clearance in mL/min to mL/s, ×0.01667; serum albumin in g/dL to g/L, ×10; SUN in mg/dL to mmol/L, ×0.357; plasma glucose in g/dL to mmol/L, ×0.05551; insulin in μU/mL to pmol/L, ×6.00.